6EO6 image
Entry Detail
PDB ID:
6EO6
Keywords:
Title:
X-ray structure of the complex between human alpha-thrombin and modified 15-mer DNA aptamer containing 5-(3-(2-(1H-indol-3-yl)acetamide-N-yl)-1-propen-1-yl)-2'-deoxyuridine residue
Biological Source:
PDB Version:
Deposition Date:
2017-10-09
Release Date:
2017-10-25
Method Details:
Experimental Method:
Resolution:
1.69 Å
R-Value Free:
0.16
R-Value Work:
0.14
R-Value Observed:
0.14
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polydeoxyribonucleotide
Description:GA63A - TBA MODIFIED APTAMER
Chain IDs:A (auth: D)
Chain Length:15
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polypeptide(L)
Description:Prothrombin
Chain IDs:C (auth: H)
Chain Length:259
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Prothrombin
Chain IDs:B (auth: L)
Chain Length:36
Number of Molecules:1
Biological Source:Homo sapiens
Peptide-like Molecules
PRD_000020
Primary Citation
Crystal structures of thrombin in complex with chemically modified thrombin DNA aptamers reveal the origins of enhanced affinity.
Nucleic Acids Res. 46 4819 4830 (2018)
PMID: 29684204 DOI: 10.1093/nar/gky268

Abstact

Thrombin-binding aptamer (TBA) is a DNA 15-mer of sequence 5'-GGT TGG TGT GGT TGG-3' that folds into a G-quadruplex structure linked by two T-T loops located on one side and a T-G-T loop on the other. These loops are critical for post-SELEX modification to improve TBA target affinity. With this goal in mind we synthesized a T analog, 5-(indolyl-3-acetyl-3-amino-1-propenyl)-2'-deoxyuridine (W) to substitute one T or a pair of Ts. Subsequently, the affinity for each analog was determined by biolayer interferometry. An aptamer with W at position 4 exhibited about 3-fold increased binding affinity, and replacing both T4 and T12 with W afforded an almost 10-fold enhancement compared to native TBA. To better understand the role of the substituent's aromatic moiety, an aptamer with 5-(methyl-3-acetyl-3-amino-1-propenyl)-2'-deoxyuridine (K; W without the indole moiety) in place of T4 was also synthesized. This K4 aptamer was found to improve affinity 7-fold relative to native TBA. Crystal structures of aptamers with T4 replaced by either W or K bound to thrombin provide insight into the origins of the increased affinities. Our work demonstrates that facile chemical modification of a simple DNA aptamer can be used to significantly improve its binding affinity for a well-established pharmacological target protein.

Legend

Protein

Chemical

Disease

Primary Citation of related structures